News and events


Bioinformatics firm Mind the Byte acquires Intelligent Pharma

The deal enables Mind the Byte, a pioneer in developing cloud technologies for computational drug design, to secure its leadership on the Spanish market and furthers its plans to become one of the key companies in the industry in Europe

Mind the Byte and Prosilico sign a strategic partnership agreement

Together, the two companies will provide a broad portfolio of in silico models covering most aspects of virtual drug discovery and development. Prosilico software will now be included in Mind the Byte's SaaS platform and both firms will promote each other's technologies.

Genomics prepares to jump to three dimensions

20 world leaders in 3D genomics will meet today until Wednesday in Barcelona at the Barcelona BioMed Conference organized by IRB Barcelona and the BBVA Foundation.

Open innovation improving drug safety evaluation

The Hospital del Mar Medical Research Institute (IMIM) and the Pompeu Fabra University (UPF) have just published a comment in the prestigious journal Nature Reviews Drug Discovery where they explain the excellent results from eTOX, a project that has facilitated a new model for collaboration among pharmaceutical companies, as well as between these and academia, where data and knowledge are shared for the purposes of improving the toxicological evaluation of drugs.